CD274 and hepatocellular carcinoma: Given the increased expression of several immune checkpoint molecules such as PD-L1, CD73, B7-H3 and others in HCC-derived CSCs, it is conceivable that CSCs exhibit immune-evasive features that may contribute to Sorafenib resistance.